Latest Breaking News On - Olga lomovskaya - Page 1 : comparemela.com

IDWeek 2023: Shionogi and Qpex Biopharma, Inc Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

FLORHAM PARK, N.J., September 07, 2023 Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcro

United statesDavid nicolauIsao teshirogiOlga lomovskayaShionogi co ltdHead officeAntimicrobial surveillance programQpex biopharma incGlobal antibiotic researchSurveillance programClinton health access initiativeDevelopment partnershipShionogi incChief executive officerQpex biopharmaSenior vice president

Shionogi USA: IDWeek 2023: Shionogi and Qpex Biopharma, Inc Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

Shionogi USA: IDWeek 2023: Shionogi and Qpex Biopharma, Inc Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergUnited statesDavid nicolauIsao teshirogiOlga lomovskayaShionogi incDevelopment partnershipClinton health access initiativeSurveillance programGlobal antibiotic researchAntimicrobial surveillance programQpex biopharma incHead officeShionogi co ltdChief executive officerQpex biopharma